Back to News
Market Impact: 0.25

Martin Zweig Detailed Fundamental Analysis

ISRGNDAQ
Company FundamentalsCorporate EarningsAnalyst InsightsInsider TransactionsHealthcare & Biotech
Martin Zweig Detailed Fundamental Analysis

Intuitive Surgical (ISRG) received a 77% rating from Validea's Martin Zweig Growth Investor model, which targets growth stocks exhibiting accelerating earnings and sales, reasonable valuations, and low debt. While the large-cap medical equipment stock passed most growth, debt, and insider transaction criteria, it notably failed tests related to its P/E ratio and earnings persistence, placing it just below the 80% threshold for 'some interest' within the strategy.

Analysis

Intuitive Surgical (ISRG) scores 77% on Validea's Martin Zweig-based Growth Investor model, indicating a generally positive but not compelling profile according to this specific quantitative strategy. The score falls just below the 80% threshold that typically signals initial interest. The company demonstrates strong current-period momentum, passing criteria for current quarter earnings, sales growth rate, and positive acceleration in EPS growth relative to both the prior three quarters and its historical rate. Furthermore, ISRG meets the model's requirements for a low total debt/equity ratio and favorable insider transaction activity. However, the model flags significant concerns, most notably a 'FAIL' on its P/E ratio, suggesting the stock's valuation is a point of friction. Critically, ISRG also fails on 'earnings persistence' and 'earnings growth rate for the past several quarters', which points to a lack of consistent, sustained earnings acceleration over a longer look-back period, despite the strength of the most recent quarter.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo